Differences between revisions 1 and 2
Revision 1 as of 2016-03-21 17:20:09
Size: 910
Editor: aerdemir
Comment:
Revision 2 as of 2016-03-22 14:28:14
Size: 1510
Editor: aerdemir
Comment:
Deletions are marked like this. Additions are marked like this.
Line 33: Line 33:
 * TBD
  * TBD
/!\ DEADLINE FOR SECOND DRAFT DATA PAPERS IS APRIL 1, 2016 /!\

 * Ahmet
  * Prepare flowcharts to describe data flow for pre-processing of joint kinematics/kinetics data.
 * Craig
  * Anatomical imaging manuscript.
  * Large-scale analysis of simulation parameters for convergence.
 * Snehal
  * Add citations and summaries to tissue data papers to the wiki for potential use to model tissue properties.
  * Pivot shift manuscript.
  * Cruciate ligament modeling & simulation.
 * Robb
  * Patellofemoral joint experimentation manuscript.
 * Tara
  * Tibiofemoral joint experimentation manuscript.

Recurring Meeting of Cleveland Clinic Core Team

Date: March 22, 2016

Time: 10:30 AM EST

Means: In person meeting

Attendees:

  1. TBD

Agenda:

  1. Discuss immediate action items from the last meeting.
  2. Continue evaluation of drafts for data manuscripts.
  3. Discuss progress of tissue testing protocol evaluation.
  4. Decide immediate action items for the next meeting.
  5. Other.

Immediate Action Items:

  • TBD
    • TBD

Ongoing Action Items:

/!\ DEADLINE FOR SECOND DRAFT DATA PAPERS IS APRIL 1, 2016 /!\

  • Ahmet
    • Prepare flowcharts to describe data flow for pre-processing of joint kinematics/kinetics data.
  • Craig
    • Anatomical imaging manuscript.
    • Large-scale analysis of simulation parameters for convergence.
  • Snehal
    • Add citations and summaries to tissue data papers to the wiki for potential use to model tissue properties.
    • Pivot shift manuscript.
    • Cruciate ligament modeling & simulation.

  • Robb
    • Patellofemoral joint experimentation manuscript.
  • Tara
    • Tibiofemoral joint experimentation manuscript.

Notes:

  1. Discuss immediate action items from the last meeting.
    • TBD
  2. Continue evaluation of drafts for data manuscripts.
    • TBD
  3. Discuss progress of tissue testing protocol evaluation.
    • TBD
  4. Decide immediate action items for the next meeting.
    • TBD
  5. Other.
    • TBD

RecurringMeetings/2016-03-22 (last edited 2016-05-04 22:09:47 by localhost)